TMC Life Sciences Berhad (0101.KL)
MYR 0.49
(-1.01%)
MYR 0.49
(-1.01%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 55.19 Million MYR | 11.77% |
| 2022 | 49.38 Million MYR | 45.61% |
| 2021 | 33.91 Million MYR | 21.5% |
| 2020 | 27.91 Million MYR | 67.44% |
| 2019 | 16.67 Million MYR | -56.4% |
| 2018 | 38.23 Million MYR | 15.65% |
| 2017 | 33.06 Million MYR | 21.44% |
| 2016 | 27.22 Million MYR | 107.72% |
| 2015 | 13.1 Million MYR | 52.43% |
| 2014 | 8.59 Million MYR | 27.57% |
| 2013 | 6.74 Million MYR | 220.49% |
| 2012 | 2.1 Million MYR | 135.09% |
| 2011 | -5.99 Million MYR | 83.15% |
| 2010 | -35.57 Million MYR | -411.7% |
| 2009 | -6.95 Million MYR | -252.46% |
| 2008 | 4.56 Million MYR | -64.89% |
| 2007 | 12.98 Million MYR | 3.08% |
| 2006 | 12.59 Million MYR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | 1.49 Million MYR | -89.01% |
| 2023 FY | 55.19 Million MYR | 11.77% |
| 2023 Q1 | 22.72 Million MYR | 50.88% |
| 2023 Q2 | 20.83 Million MYR | -8.31% |
| 2023 Q3 | 13.63 Million MYR | -34.55% |
| 2022 Q1 | 10.78 Million MYR | -11.02% |
| 2022 Q3 | 14.3 Million MYR | 40.96% |
| 2022 Q4 | 15.06 Million MYR | 5.31% |
| 2022 FY | 49.38 Million MYR | 45.61% |
| 2022 Q2 | 10.14 Million MYR | -5.94% |
| 2021 Q3 | 7.56 Million MYR | -17.48% |
| 2021 FY | 33.91 Million MYR | 21.5% |
| 2021 Q4 | 12.12 Million MYR | 60.31% |
| 2021 Q1 | 5.43 Million MYR | -6.47% |
| 2021 Q2 | 9.16 Million MYR | 68.64% |
| 2020 Q1 | 10.71 Million MYR | 0.0% |
| 2020 Q2 | 7.06 Million MYR | -34.03% |
| 2020 Q4 | 5.81 Million MYR | 28.6% |
| 2020 FY | 27.91 Million MYR | 67.44% |
| 2020 Q3 | 4.51 Million MYR | -36.09% |
| 2019 FY | 16.67 Million MYR | -56.4% |
| 2019 Q1 | 9.65 Million MYR | -11.51% |
| 2019 Q3 | 8.73 Million MYR | -18.9% |
| 2019 Q2 | 10.76 Million MYR | 11.55% |
| 2018 Q1 | 10.39 Million MYR | 13.04% |
| 2018 Q3 | 8.24 Million MYR | -12.56% |
| 2018 Q4 | 10.91 Million MYR | 32.34% |
| 2018 FY | 38.23 Million MYR | 15.65% |
| 2018 Q2 | 9.42 Million MYR | -9.3% |
| 2017 Q1 | 12.43 Million MYR | 100.03% |
| 2017 FY | 33.06 Million MYR | 21.44% |
| 2017 Q3 | 7.6 Million MYR | 19.06% |
| 2017 Q2 | 6.39 Million MYR | -48.59% |
| 2017 Q4 | 9.19 Million MYR | 20.86% |
| 2016 FY | 27.22 Million MYR | 107.72% |
| 2016 Q1 | 3.43 Million MYR | -23.34% |
| 2016 Q2 | 6.58 Million MYR | 91.76% |
| 2016 Q3 | 7.21 Million MYR | 9.59% |
| 2016 Q4 | 6.21 Million MYR | -13.91% |
| 2015 Q4 | 4.48 Million MYR | 49.87% |
| 2015 Q2 | 3.09 Million MYR | 21.76% |
| 2015 Q3 | 2.99 Million MYR | -3.36% |
| 2015 FY | 13.1 Million MYR | 52.43% |
| 2015 Q1 | 2.54 Million MYR | 167.76% |
| 2014 FY | 8.59 Million MYR | 27.57% |
| 2014 Q4 | 949 Thousand MYR | -47.25% |
| 2014 Q3 | 1.79 Million MYR | -3.64% |
| 2014 Q2 | 1.86 Million MYR | 333.18% |
| 2014 Q1 | 431 Thousand MYR | -84.62% |
| 2013 Q1 | -316 Thousand MYR | -139.16% |
| 2013 Q2 | 2.51 Million MYR | 895.25% |
| 2013 Q3 | 1.74 Million MYR | -30.76% |
| 2013 FY | 6.74 Million MYR | 220.49% |
| 2013 Q4 | 2.8 Million MYR | 61.09% |
| 2012 Q2 | 856 Thousand MYR | 478.38% |
| 2012 Q1 | 148 Thousand MYR | 105.34% |
| 2012 FY | 2.1 Million MYR | 135.09% |
| 2012 Q4 | 807 Thousand MYR | 240.51% |
| 2012 Q3 | 237 Thousand MYR | -72.31% |
| 2011 Q2 | -2.27 Million MYR | -24.07% |
| 2011 Q3 | -579 Thousand MYR | 74.58% |
| 2011 Q4 | -2.77 Million MYR | -378.58% |
| 2011 Q1 | -1.83 Million MYR | 0.0% |
| 2011 FY | -5.99 Million MYR | 83.15% |
| 2010 FY | -35.57 Million MYR | -411.7% |
| 2009 FY | -6.95 Million MYR | -252.46% |
| 2008 FY | 4.56 Million MYR | -64.89% |
| 2007 FY | 12.98 Million MYR | 3.08% |
| 2006 FY | 12.59 Million MYR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| IHH Healthcare Berhad | 4.25 Billion MYR | 98.703% |
| KPJ Healthcare Berhad | 515.92 Million MYR | 89.301% |